| 1 |
28087064 | Effect of CYP2D6 polymorphisms on the pharmacokinetics of propafenone and its two main metabolites. | 2017 Jun |
2 |
| 2 |
28261841 | A sensitive quantitative assay for the determination of propafenone and two metabolites, 5-hydroxypropafenone and N-depropylpropafenone, in human K2EDTA plasma using LC-MS/MS with ESI operated in positive mode. | 2017 Oct |
2 |
| 3 |
28520383 | Propafenone Therapy and CYP2D6 Genotype | 2012 |
2 |
| 4 |
16609933 | Capillary electrophoretic investigation of the enantioselective metabolism of propafenone by human cytochrome P-450 SUPERSOMES: Evidence for atypical kinetics by CYP2D6 and CYP3A4. | 2006 Apr |
1 |
| 5 |
11749780 | Stereoselective metabolism of propafenone by human liver CYP3A4 expressed in transgenic Chinese hamster CHL cells lines. | 2001 Oct |
3 |
| 6 |
10917404 | Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: in vitro studies using human liver microsomes. | 2000 Aug |
1 |
| 7 |
10945315 | Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings. | 2000 Jul |
1 |
| 8 |
11113932 | Stereoselective determination of propafenone enantiomers in transgenic Chinese hamster CHL cells expressing human cytochrome P450. | 2000 Nov |
1 |
| 9 |
10591535 | Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6. | 1999 Oct |
1 |
| 10 |
8423765 | Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites. | 1993 Jan |
3 |